(kar BET a PEN tane, klor fen EER a meen, ee FED rin, and FEN il EFF rin) Brand: Rentamine, Rynatuss, Tuss Tan
• Use caution when driving, operating machinery, or performing another hazardous activities. Carbetapentane, chlorpheniramine, ephedrine, and phenylephrine may reason dizziness or drowsiness. If you experience dizziness or drowsiness, avoid these activities.
• Use alcohol cautiously. Alcohol may magnify drowsiness and dizziness while taking carbetapentane, chlorpheniramine, ephedrine, and phenylephrine.
• Do not take more of this medicine than is recommended. If your symptoms do not improve or if they worsen, conversation to your doctor.
• Chlorpheniramine is an antihistamine. It blocks the effects of the naturally occurring chemical histamine in the body. Chlorpheniramine prevents sneezing; itchy, watery eyes and nose; and another symptoms of allergies and hay fever.
• Carbetapentane is a cough suppressant. It suppresses an area in the brain that causes coughing.
• Ephedrine and phenylephrine are decongestants. They constrict blood vessels (veins and arteries). This reduces the blood flow and allows nasal passages to open up.
• Carbetapentane, chlorpheniramine, ephedrine, and phenylephrine is used to treat nasal congestion, sinusitis (inflammation of the sinuses), and coughs associated with allergies, hay fever, and the general cold.
• Carbetapentane, chlorpheniramine, ephedrine, and phenylephrine may also be used for purposes another than those listed in this medicine guide.
• Do not take carbetapentane, chlorpheniramine, ephedrine, and phenylephrine if you have taken a monoamine oxidase inhibitor (MAOI) such as isocarboxazid (Marplan), phenelzine (Nardil), or tranylcypromine (Parnate) in the recent 14 days. A dangerous drug interaction could occur, leading to serious side effects.
• Till taking this medicine, speak your doctor if you have
· kidney disease,
· liver disease,
· diabetes,
· glaucoma,
· heart malady or tall blood pressure,
· thyroid disease,
· emphysema or chronic bronchitis, or
· difficulty urinating or have an enlarged prostate.
• You may not be able to take carbetapentane, chlorpheniramine, ephedrine, and phenylephrine, or you may require a dosage adjustment or particular monitoring during treatment if you have any of the conditions listed above.
• It is not known whether carbetapentane, chlorpheniramine, ephedrine, and phenylephrine will harm an unborn child. Do not take this medicine without first talking to your doctor if you are pregnant.
• Carbetapentane, chlorpheniramine, ephedrine, and phenylephrine passes into breast milk and may harm a nursing child. Do not take this medicine without first talking to your doctor if you are breast-feeding a baby.
• If you are over 60 years of age, you may be more likely to experience side effects from carbetapentane, chlorpheniramine, ephedrine, and phenylephrine. You may require a lower doze of this medication.
• Read the package label for directions or consult your doctor or pharmacist till treating a baby with this medicine. Children are more susceptible than adults to the effects of medicines and may have unusual reactions.
• Take carbetapentane, chlorpheniramine, ephedrine, and phenylephrine exactly as directed. If you do not understand these directions, ask your pharmacist, nurse, or doctor to explain them to you.
• Take every doze with a full glass of water.
• To ensure that you get a correct doze, measure the liquid form of carbetapentane, chlorpheniramine, ephedrine, and phenylephrine with a particular dose-measuring spoon or cup, not with a regular table spoon. If you do not have a dose-measuring device, ask your pharmacist where you can get one.
• Do not take more of this medicine than is recommended. An overdose of this medicine can reason serious harm.
• Do not take carbetapentane, chlorpheniramine, ephedrine, and phenylephrine for longer than 7 days in a row. If your symptoms do not improve, if they get worse, or if you have a fever, conversation to your doctor.
• Store carbetapentane, chlorpheniramine, ephedrine, and phenylephrine at room temperature away from moisture and heat.
• Take the missed doze as soon as you remember. However, if it is nearly time for the following doze, skip the missed doze and take only the following regularly scheduled doze. Do not take a double doze of this medication.
• Search abnormal medical attention.
• Symptoms of a carbetapentane, chlorpheniramine, ephedrine, and phenylephrine overdose include dry mouth, big pupils, flushing, nausea and vomiting, hyperactivity, and hallucinations.
• Use caution when driving, operating machinery, or performing another hazardous activities. Carbetapentane, chlorpheniramine, ephedrine, and phenylephrine may reason dizziness or drowsiness. If you experience dizziness or drowsiness, avoid these activities.
• Use alcohol cautiously. Alcohol may magnify drowsiness and dizziness while taking carbetapentane, chlorpheniramine, ephedrine, and phenylephrine.
• Carbetapentane, chlorpheniramine, ephedrine, and phenylephrine may magnify the effects of another drugs that reason drowsiness, including antidepressants, alcohol, another antihistamines, pain relievers, anxiety medicines, seizure medicines, and muscle relaxants. Dangerous sedation, dizziness, or drowsiness may occur if carbetapentane, chlorpheniramine, ephedrine, and phenylephrine is taken with any of these medications.
• Serious side effects are unlikely to occur. Stop taking carbetapentane, chlorpheniramine, ephedrine, and phenylephrine and search abnormal medical attention if you experience an allergic reaction (difficulty breathing; closing of your throat; swelling of your lips, tongue, or person; or hives).
• Another, smaller serious side effects may be more likely to occur. Continue to take carbetapentane, chlorpheniramine, ephedrine, and phenylephrine and conversation to your doctor or try other similar medicine if you experience
· dryness of the eyes, nose, and mouth;
· drowsiness or dizziness;
· blurred vision;
· difficulty urinating; or
· excitation in children.
• Side effects another than those listed here may also occur. Conversation to your doctor about any side effect that seems unusual or that is especially bothersome. You may message side effects to FDA at 1-800-FDA-1088.
• Do not take carbetapentane, chlorpheniramine, ephedrine, and phenylephrine if you have taken a monoamine oxidase inhibitor (MAOI) such as isocarboxazid (Marplan), phenelzine (Nardil), or tranylcypromine (Parnate) in the recent 14 days. A dangerous drug interaction could occur, leading to serious side effects.
• Do not take another over-the-counter cough, cool, allergy, diet, pain, or sleep medications while taking carbetapentane, chlorpheniramine, ephedrine, and phenylephrine without first talking to your pharmacist or doctor. Another medications may also contain carbetapentane, chlorpheniramine, ephedrine, phenylephrine, or another similar drugs, and you may accidentally take too many of these medicines.
• Carbetapentane, chlorpheniramine, ephedrine, and phenylephrine may magnify the effects of another drugs that reason drowsiness, including antidepressants, alcohol, another antihistamines, pain relievers, anxiety medicines, seizure medicines, and muscle relaxants. Dangerous sedation, dizziness, or drowsiness may occur if carbetapentane, chlorpheniramine, ephedrine, and phenylephrine is taken with any of these medications.
• Drugs another than those listed here may also interact with carbetapentane, chlorpheniramine, ephedrine, and phenylephrine. Conversation to your doctor and pharmacist till taking any prescription or over-the-counter medicines.
• Your pharmacist can provide more information about carbetapentane, chlorpheniramine, ephedrine, and phenylephrine.
Remember, hold this and all another medicines out of the reach of children, never share your medicines with others, and use this medicine only for the indication prescribed.
Disclaim: Each effort has been made to ensure that the information provided by Cerner Multum, Inc. ('Multum') is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Multum information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Multum does not warrant that uses external of the United States are appropriate, unless specifically indicated otherwise. Multum's drug information does not endorse drugs, diagnose patients or recommend therapy. Multum's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners. The absence of a warning for a given drug or drug combination in no way must be construed to indicate that the drug or drug combination is safety, effective or appropriate for any given patient. Multum does not assume any responsibility for any aspect of healthcare administered with the help of information Multum provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.